Discussions | 17 Sep 2013 European Commission Approves Alemtuzumab (Lemtrada) Bob Finn This follows the Commission's August 30 approval of teriflunomide (Aubagio). Here's Genzyme's press release. Comments? Genzyme Press release re Alemtuzumab from Gavin Giovannoni CommentRecommendBookmarkWatch
